Effects of cholesterol reduction on BP response to mental stress in patients with high cholesterol

American Journal of Hypertension

Volumn 10, Issue 6, 1997, Pages 592-599

  Sung, Bong Hee ^a   Izzo Jr , Joseph L ^a   Wilson, Michael F ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Blood pressure; Cholesterol; Hypercholesterolemia; Mental arithmetic test

Indexed keywords

MEVINOLIN;

ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MENTAL STRESS; NORMAL HUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ADULT; BLOOD PRESSURE; CHOLESTEROL; FEMALE; HUMANS; MALE; MIDDLE AGED; STRESS, PSYCHOLOGICAL;

EID: 0343990838     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00050-2     Document Type: Article

References (30)

1. Fuh MMT, Shieh SM, Wu DA, et al. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension. Arch Intern Med. 147:1987;1035-1038.
2. Ferrannini E, Natali A, Cerri M, et al. Hypertension: a metabolic disorder? Diabet Metab. 15:1989;284-291.
3. Creager MA, Gallagher SJ, Girerd XJ, et al. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 90:1992;1248-1253.
4. Cohen RA, Zitnay KM, Haudenschild CC, et al. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res. 63:1988;903-910.
5. Casino RC, Kilcoyne CM, Quyyumi AA, et al. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation. 88:1993;2541-2547.
6. Shimokawa H, Vanhoutte PM. Impaired endothelium-dependent relaxation to aggregating platelets and related substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ Res. 64:1989;900-914.
7. Merkel LA, Rivera LM, Bilder GE, et al. Differential alteration of vascular reactivity in rabbit aorta with modest elevation of serum cholesterol. Circ Res. 67:1990;550-555.
8. Drexler H, Zeiher AM. Endothelial function in human coronary arteries in vivo. Hypertension. 18:((suppl II)):1991;II-90-II-99.
9. Creager MA, Cooke JP, Mendelsohn ME, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 86:1990;228-234.
10. Chowienczyk PJ, Watts GF, Cockcroft JR, et al. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolemia. Lancet. 340:1992;1430-1432.
11. National Education Programs Working Group report on the management of patients with hypertension and high blood cholesterol. Ann Intern Med. 114:1991;224-237.
12. Matthews KA, Woodall KL, Allen MT. Cardiovascular reactivity to stress predicts future BP status. Hypertension. 22:1993;479-485.
13. Mundal R, Kjedsen SE, Sandvik L, et al. Exercise BP predicts cardiovascular mortality in middle-aged men. Hypertension. 24:1994;56-62.
14. Falkner B, Onesti G, Angelakos ET, et al. Cardiovascular response to mental stress in normal adolescents with hypertensive parents. Hypertension. 1:1979;23-30.
15. Giaconi S, Palombo C, Marabotti C, et al. Casual BP, cardiovascular reactivity tests and BP monitoring in borderline hypertension. J Hypertens. 4:((suppl 5)):1986;S331-S333.
16. Allain CC, Poon LS, Chan SCG, et al. Enzymatic determination of total serum cholesterol. Clin Chem. 20:1974;470-495.
17. Steele WB, Koehle DF, Azar MM, et al. Enzymatic determination of cholesterol in high density lipoprotein fractions prepared by a precipitation technique. Clin Chem. 22:1976;98.
18. Sempos CT, Cleeman JI, Carroll MD, et al. Prevalence of high blood cholesterol among US adults: an update based on guidelines from the second part report of the national cholesterol education program adult treatment panel. JAMA. 269:1993;3009-3014.
19. Verbeuren TJ, Jordaens FH, Zonnekeyn LL, et al. Effect of hypercholesterolemia on vascular reactivity in the rabbit. Circ Res. 58:1986;552-564.
20. Andrews HE, Bruckdorfer KR, Dunn RC, et al. Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature. 327:1987;237-239.
21. Sung BH, Grover A, Dandona P, et al. Insulin-mediated vasodilation is blunted in hypercholesterolemia (abst). Am J Hypertens. 8:(4):1995;111A.
22. Grover A, Padginton C, Wilson MF, et al. Insulin attenuates norepinephrine-induced venoconstriction: an ultrasonographic study. Hypertension. 25:((part 2)):1995;779-784.
23. Bradford RH, Shear CL, Chremos AN, et al. Expanded clinical evaluation of lovastatin (EXCEL) study results: two-year efficacy and safety follow-up. Am J Cardiol. 74:1994;667-673.
24. Shear CL, Franklin FA, Stinnett S, et al. Expanded clinical evaluation of lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins. Circulation. 85:1992;1293-1303.
25. Pool JL, Shear CL, Downton M, et al. Lovastatin and coadministrated antihypertensive/cardiovascular agents. Hypertension. 19:1992;242-248.
26. Roullet JB, Xue H, Pappu AS, et al. Mevalonate availability and cardiovascular functions. Proc Natl Acad Sci USA. 90:(24):1993;11728-11732.
27. Anderson TJ, Meredith IT, Yeung AC, et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 332:1995;488-493.
28. Harrison DG, Armstrong ML, Freidman PC. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest. 80:1987;1808-1811.
29. Brown BG, Zhao XQ, Sacco DE, et al. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation. 87:1993;1782-1791.
30. Brown G, Albers JJ, Fisher LD. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apo-lipoprotein B. N Engl J Med. 323:1990;1289-1298.